Multi-omics in high-grade serous ovarian cancer: Biomarkers from genome to the immunome
出版年份 2018 全文链接
标题
Multi-omics in high-grade serous ovarian cancer: Biomarkers from genome to the immunome
作者
关键词
-
出版物
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
Volume -, Issue -, Pages e12975
出版商
Wiley
发表日期
2018-05-21
DOI
10.1111/aji.12975
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Can innate immune system targets turn up the heat on 'cold' tumours?
- (2018) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
- (2017) Mark Ayers et al. JOURNAL OF CLINICAL INVESTIGATION
- A brief review of the management of platinum-resistant–platinum-refractory ovarian cancer
- (2017) Bryan Oronsky et al. MEDICAL ONCOLOGY
- Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
- (2017) Catherine M Phelan et al. NATURE GENETICS
- Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes
- (2017) Yi Kan Wang et al. NATURE GENETICS
- Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma
- (2017) Jennifer Ducie et al. Nature Communications
- The Prognostic 97 Chemoresponse Gene Signature in Ovarian Cancer
- (2017) Abel Matondo et al. Scientific Reports
- A library-based screening method identifies neoantigen-reactive T cells in peripheral blood prior to relapse of ovarian cancer
- (2017) Spencer D. Martin et al. OncoImmunology
- Identification of a six-lncRNA signature associated with recurrence of ovarian cancer
- (2017) Kai Yang et al. Scientific Reports
- Proteomics analysis to reveal biological pathways and predictive proteins in the survival of high-grade serous ovarian cancer
- (2017) Hongyu Xie et al. Scientific Reports
- Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
- (2016) Hui Zhang et al. CELL
- Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer
- (2016) D. R. Kroeger et al. CLINICAL CANCER RESEARCH
- Neoadjuvant Chemotherapy of Ovarian Cancer Results in Three Patterns of Tumor-Infiltrating Lymphocyte Response with Distinct Implications for Immunotherapy
- (2016) Charlotte S. Lo et al. CLINICAL CANCER RESEARCH
- Monocyte and interferon based therapy for the treatment of ovarian cancer
- (2016) Daniel S. Green et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Moving beyond the platinum sensitive/resistant paradigm for patients with recurrent ovarian cancer
- (2016) Ronald D. Alvarez et al. GYNECOLOGIC ONCOLOGY
- PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer
- (2016) John R. Webb et al. GYNECOLOGIC ONCOLOGY
- Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
- (2016) Jonathan M. Pitt et al. IMMUNITY
- The host STING pathway at the interface of cancer and immunity
- (2016) Leticia Corrales et al. JOURNAL OF CLINICAL INVESTIGATION
- A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics
- (2016) Aline Poersch et al. Journal of Proteomics
- Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study
- (2016) Marina Bagnoli et al. LANCET ONCOLOGY
- PTEN deficiency promotes macrophage infiltration and hypersensitivity of prostate cancer to IAP antagonist/radiation combination therapy
- (2016) Chris W.D. Armstrong et al. Oncotarget
- Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer
- (2016) Kyle C. Strickland et al. Oncotarget
- Metabolic phenotyping for monitoring ovarian cancer patients
- (2016) Chaofu Ke et al. Scientific Reports
- Discovery of candidate tumor biomarkers for treatment with intraperitoneal chemotherapy for ovarian cancer
- (2016) Brandon-Luke L. Seagle et al. Scientific Reports
- STING Pathway Activation Stimulates Potent Immunity against Acute Myeloid Leukemia
- (2016) Emily Curran et al. Cell Reports
- A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer
- (2015) M Koti et al. BRITISH JOURNAL OF CANCER
- Ovarian cancer treatment: The end of empiricism?
- (2015) Stephanie Lheureux et al. CANCER
- New insights into tumor immunity revealed by the unique genetic and genomic aspects of ovarian cancer
- (2015) Brad H Nelson CURRENT OPINION IN IMMUNOLOGY
- Predictive markers of chemoresistance in advanced stages epithelial ovarian carcinoma
- (2015) Claire Bonneau et al. GYNECOLOGIC ONCOLOGY
- Whole–genome characterization of chemoresistant ovarian cancer
- (2015) Ann-Marie Patch et al. NATURE
- Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer
- (2015) P. A. Konstantinopoulos et al. Cancer Discovery
- A metabolomic approach to identifying platinum resistance in ovarian cancer
- (2015) Laila M Poisson et al. Journal of Ovarian Research
- Tumor-intrinsic oncogene pathways mediating immune avoidance
- (2015) Stefani Spranger et al. OncoImmunology
- Analysis of Chemotherapeutic Response in Ovarian Cancers Using Publicly Available High-Throughput Data
- (2014) J. G. Bosquet et al. CANCER RESEARCH
- Mechanisms of Hypoxia-Mediated Immune Escape in Cancer
- (2014) I. B. Barsoum et al. CANCER RESEARCH
- Up-regulation of the interferon-related genes inBRCA2knockout epithelial cells
- (2014) Hong Xu et al. JOURNAL OF PATHOLOGY
- Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer
- (2014) Gottfried E. Konecny et al. JNCI-Journal of the National Cancer Institute
- Risk Prediction for Late-Stage Ovarian Cancer by Meta-analysis of 1525 Patient Samples
- (2014) Markus Riester et al. JNCI-Journal of the National Cancer Institute
- Ovarian cancer
- (2014) Gordon C Jayson et al. LANCET
- Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer
- (2014) L. Yang et al. Molecular Systems Biology
- Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
- (2014) Antonella Sistigu et al. NATURE MEDICINE
- Interferons and Their Stimulated Genes in the Tumor Microenvironment
- (2014) HyeonJoo Cheon et al. SEMINARS IN ONCOLOGY
- microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial–mesenchymal transition
- (2014) Aditya Parikh et al. Nature Communications
- Current Approaches and Challenges in Managing and Monitoring Treatment Response in Ovarian Cancer
- (2014) Charlotte S Marcus et al. Journal of Cancer
- Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer
- (2013) Madhuri Koti et al. BMC CANCER
- Surveillance of the Tumor Mutanome by T Cells during Progression from Primary to Recurrent Ovarian Cancer
- (2013) Darin A. Wick et al. CLINICAL CANCER RESEARCH
- Predicting time to ovarian carcinoma recurrence using protein markers
- (2013) Ji-Yeon Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling
- (2013) Ali Bashashati et al. JOURNAL OF PATHOLOGY
- Influence of tumour micro-environment heterogeneity on therapeutic response
- (2013) Melissa R. Junttila et al. NATURE
- Inferring tumour purity and stromal and immune cell admixture from expression data
- (2013) Kosuke Yoshihara et al. Nature Communications
- Epigenetic Resensitization to Platinum in Ovarian Cancer
- (2012) D. Matei et al. CANCER RESEARCH
- Discrimination between malignant and benign ovarian tumors by plasma metabolomic profiling using ultra performance liquid chromatography/mass spectrometry
- (2012) Tao Zhang et al. CLINICA CHIMICA ACTA
- CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27- Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian Cancer
- (2012) J. S. Nielsen et al. CLINICAL CANCER RESEARCH
- Long-Term Ovarian Cancer Survival Associated With Mutation in BRCA1 or BRCA2
- (2012) John R. McLaughlin et al. JNCI-Journal of the National Cancer Institute
- BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma
- (2012) Jessica N McAlpine et al. MODERN PATHOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Targeting genetic and epigenetic alterations in the treatment of serous ovarian cancer
- (2011) Johanne I. Weberpals et al. Cancer Genetics
- BRCA1 mRNA expression and outcome to neoadjuvant cisplatin-based chemotherapy in bladder cancer
- (2010) A. Font et al. ANNALS OF ONCOLOGY
- Urine Metabolite Analysis Offers Potential Early Diagnosis of Ovarian and Breast Cancers
- (2010) C. M. Slupsky et al. CLINICAL CANCER RESEARCH
- Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas
- (2009) D. Etemadmoghadam et al. CLINICAL CANCER RESEARCH
- Minireview: Epigenetic Changes in Ovarian Cancer
- (2009) Curt Balch et al. ENDOCRINOLOGY
- Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors
- (2009) Katy Milne et al. PLoS One
- Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer
- (2008) Ninke Leffers et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
- (2008) R. W. Tothill et al. CLINICAL CANCER RESEARCH
- Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type and BRCA1 loss
- (2008) Blaise Clarke et al. MODERN PATHOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started